I've done me head in trying to relate the numbers to the reasons offered for the lower efficacy.
They (Placebo or other group or both?) are using a number of strategies for flu prevention which has um reduced infection, which in turn, has lowered efficacy???? Doesnt that sound oh so counter intuitive????
- Forums
- ASX - By Stock
- BTA
- Ann: Phase III prophylaxis trial for CS-8958
Ann: Phase III prophylaxis trial for CS-8958 , page-19
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online